AGC Biologics Appoints Kevin Ingham as the New General Manager/Site Head of Their Seattle, Washington Site

Seattle, Aug. 2 (Korea Bizwire) — AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced a new appointment to oversee the strategic development and operational excellence in clinical and commercial biologics production at its Seattle, Washington site. Effective August 2, 2021, Kevin Ingham will join the Seattle team as the [...]